Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
12:44pMODERNA : U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots
RE
12:01pABIVAX : Nombre d'actions composant le capital social et nombre total de droits de vote au 30.09.21
DJ
10:01aMORPHOSYS AG : Release according to -2-
DJ
10:01aMORPHOSYS AG : Release according to -3-
DJ
08:52aSANOFI : Gets a Buy rating from UBS
MD
06:46aPRESS RELEASE : Pfizer and BioNTech Announce Phase -4-
DJ
06:46aPRESS RELEASE : Pfizer and BioNTech Announce Phase -3-
DJ
06:46aPRESS RELEASE : Pfizer and BioNTech Announce Phase -2-
DJ
06:46aPRESS RELEASE : Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
DJ
06:31aPRESS RELEASE : Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF(TM) from the European Medicines Agency
DJ
05:58aIntellia Gets FDA Orphan Designation for NTLA-2001 in ATTR Amyloidosis
DJ
05:34aPFIZER, BIONTECH : Phase 3 Study Shows High Efficacy of Covid-19 Vaccine Booster
DJ
05:27aMORPHOSYS : Buy rating from Berenberg
MD
05:24aSARTORIUS VORZUEGE : Warburg Research remains its Buy rating
MD
05:17aPRESS RELEASE : Sangui BioTech International Inc.: Granulox is awarded the prestigious Prix Galien
DJ
Discover
05:05aFRESENIUS SE : Barclays reaffirms its Buy rating
MD
05:05aFMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reaffirms its Neutral rating
MD
05:01aROCHE HOLDINGS AG : JP Morgan sticks Neutral
MD
04:48aASTRAZENECA : JP Morgan reaffirms its Buy rating
MD
04:36aDanaher Sees Core Sales Growth of More Than 20% in 2021
DJ
04:28aDanaher 3Q Sales, Profits Grow, Lifted by Covid-19 Work
DJ
03:39aSHIONOGI : Japan's Shionogi starts Phase II/III clinical trial for new COVID-19 vaccine
RE
02:50aROCHE HOLDINGS AG : Credit Suisse reiterates its Neutral rating
MD
02:31aPharnext confirms details for 2021 Hybrid Research & Development Day
DJ
02:31aPharnext précise l'agenda de l'édition 2021 de -2-
DJ
02:31aPharnext précise l'agenda de l'édition 2021 de ses journées dédiées à ses activités de recherche et développement
DJ
02:30aVitrolife AB Announces CFO Changes, Effective 1 January 2022
CI
02:21aSARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
02:00aCareTech Holdings PLC Announces Executive Changes
CI
02:00aContextVision Reports Sales Results for the Third Quarter 2021
CI
02:00aOncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
CI
01:45aAlligator Announces First Patient Dosed in Phase II Clinical Trial with Shanghai Henlius Biotech, Inc. & AbClon, Inc
CI
01:36aIpsen S.A. Reports Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
01:36aIpsen S.A. Revises Sales Guidance for the Year 2021
CI
01:33aNOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
01:30aTheraVet Announces Commercial launch of BIOCERA-VET? in France and The Netherlands
CI
10/21Certain Ordinary Shares of ABIVAX Soci?t? Anonyme are subject to a Lock-Up Agreement Ending on 21-OCT-2021.
CI
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
10/20SHIONOGI : Japan's Shionogi announces start of Phase II/III clinical trial for new COVID-19 vaccine
RE
10/20Alphamab Oncology and CSPC Pharmaceutical Group Limited Jointly Announces IND Application for A Phase III Clinical Study
CI
10/20Shionogi & Co., Ltd. Announces Progress of Phase 2/3 Clinical Trial for New Formulation of Covid-19 Recombinant Protein-Based Vaccine
CI
10/20U.S. bars Malaysian glove maker Supermax over alleged labour abuses
RE
10/20CDC ACIP Unanimously Votes to Provisionally Recommend Merck?s VAXNEUVANCE?
CI
10/20Rhythm Biosciences Limited Announces Commercially Manufactured ColoSTAT? Test Kits Deliver Consistent, High Accuracy Outcomes - Equivalent To Study 6
CI
10/20Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
CI
10/20BAYER : Mexico's agriculture minister say Mexico will not limit GMO corn imports from U.S.
RE
10/20Dimerix Limited Announces First Approvals Received for Start of Phase 3 FSGS Trial
CI
10/20Moderna, Inc. Announces U.S. Food and Drug Administration Authorized for Emergency Use A Booster Dose of the Moderna Covid-19 Vaccine (mRNA-1273)
CI
10/20CytoDyn Announces Delaware Court has Denied Paul Rosenbaum?s Motion to Prevent Annual Meeting from Taking Place
CI
10/20The New England Journal of Medicine Publishes the Results of the Native Phase IIb Clinical Trial with Lanifibranor in Nash
CI
10/20MODERNA : U.S. FDA clears Moderna and J&J boosters, backs 'mix-and-match' strategy
RE
10/20Guardant Health Appoints Myrtle Potter to Board of Directors
CI
10/20Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
10/20Tenet Healthcare Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
10/20Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter of 2021
CI
10/20Tenet Healthcare Corporation Revises Earnings Guidance for the Year 2021
CI
10/20Zai Lab Limited Announces Positive Results from a Randomized and Efficacy of a Topical Formulation of Zl-1102 in Adults with Mild-To-Moderate Chronic Plaque Psoriasis
CI
10/20Absci Corporation Opens Door to New Biotechnology Campus
CI
10/20PRESS RELEASE : MorphoSys AG: First Patient Dosed -2-
DJ
10/20PRESS RELEASE : MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy
DJ
10/20OncoSec Medical Incorporated Announces Step Down of Chris Twitty, Chief Scientific Officer
CI
10/20MorphoSys AG Announces First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin a Nephropathy
CI
10/20MODERNA : U.S. administers 410.2 mln doses of COVID-19 vaccines - CDC
RE
10/20Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2021
CI
10/20Sesen Bio Up 33% After Regulatory Updates
DJ
Discover
10/20CANSINO BIOLOGICS : Restricting travel over vaccine type could be discrimination, PAHO warns
RE
10/20U.K. in Agreements for Merck/Ridgeback, Pfizer Covid-19 Antivirals in Development
DJ
10/20Amplitude Surgical SA Provides Earnings Guidance for the Year 2021-22
CI
10/20Waters Corporation Announces Five-Year Research Partnership to Develop New Analytical Solutions for Bioprocessing and Biomanufacturing
CI
10/20Cigna Corporation Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area
CI
1  2  3  4  5  6  7  8  9  10Next